Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells.

Saegusa, M

Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells. [electronic resource] - The Journal of pathology Dec 2008 - 521-32 p. digital

Publication Type: Journal Article

1096-9896

10.1002/path.2404 doi


Base Sequence
Cell Line, Tumor
Cell Transdifferentiation
E1A-Associated p300 Protein--metabolism
Early Growth Response Protein 1--genetics
Endometrial Neoplasms--metabolism
Estrogen Receptor alpha--genetics
Female
Gene Expression
Gene Expression Regulation, Neoplastic
Humans
Immunohistochemistry
Molecular Sequence Data
Promoter Regions, Genetic
Reverse Transcriptase Polymerase Chain Reaction
Statistics, Nonparametric
TCF Transcription Factors--genetics
Transcription Factor 7-Like 2 Protein
Transcriptional Activation
Transfection
Up-Regulation
beta Catenin--metabolism